Matches 1 - 50 out of 296 1 2 3 4 5 6 >


Match Document Document Title
US20140121191 Oral Energy Supplement and Related Methods  
The present invention relates to oral dosage formulations consisting of at least one active ingredient contained in a plurality of hydrophobic carriers dispersed in an aqueous medium comprising a...
US20130123228 PROMOTING AXON REGENERATION IN THE ADULT CNS THROUGH CONTROL OF PROTEIN TRANSLATION  
Survival of, or axon regeneration in a lesioned mature central nervous system (CNS) neuron is promoted by (a) contacting the neuron with a therapeutically effective amount of an exogenous...
US20100331819 Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy  
This invention relates to photodynamic therapy (PDT), more specifically PDT for atherosclerotic plaque via delivering PDT-loaded nanoparticles such as liposomes, polymersomes, micelles and...
US20100310660 DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY  
The invention provides a dry powder microparticle for pulmonary delivery, which comprises at least one nanoparticle in the form of liposome or micelle wherein the nanopaparticle encapsulates one...
US20110236508 L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION  
A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the...
US20120282297 METHOD FOR TREATING CONSTIPATION  
The invention relates to methods and compositions for the treatment of constipation. The method of the invention involves administration of a suppository containing chlorophyll, chlorophyllin...
US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance  
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method...
US20120289492 METHODS OF TREATING MITOCHONDRIAL DISORDERS USING METALLOPORPHYRINS  
Methods of treating a mitochondrial disorder including epilepsy, a neurological disorder, an inherited mitochondrial disease or inherited epilepsies, a pediatric epilepsy, an encephalopathy or a...
US20110243854 Methods and systems for identifying modulators of longevity  
Methods of treating disorders such as neurofibromatosis-1 are provided, including methods in which catalytic antioxidants such as metalloporphyrins are administered. Methods of regulating...
US20120065181 METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS  
Described herein are methods of treating ischemic injury comprising administering to a subject in need thereof a therapeutically effective amount of a substituted porphyrin compound. Also...
US20050085454 Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance  
A composition for the treatment, prevention or management of a condition in primates, especially humans comprising a phenolic antioxidant-chromium complex.
US20140371192 ALPHA-FORM ZINC-PHTHALOCYANINE NANOWIRES HAVING ENHANCED WATER SOLUBILITY AND WATER DISPERSIBILITY, COMPOSITE OF AN ALPHA-FORM ZINC-PHTHALOCYANINE NANOWIRE/PHENOTHIAZINE, AND METHOD FOR PREPARING SAME  
The present invention relates to alpha-form zinc-phthalocyanine nanowires (ZnPc NWs) having enhanced water solubility and water dispersibility, to a composite of an alpha-form zinc-phthalocyanine...
US20130012443 METHODS OF TREATMENT OF CENTRAL NERVOUS SYSTEM HEMORRHAGE USING PROTOPORPHYRIN IX-FE COMPOUNDS  
Described herein are methods and compositions relating to treatment of tissue damage resulting from a central nervous system (CNS) hemorrhage with a protoporphyrin IX-Fe compound.
US20140093517 OXIDIZED LDL AS A BIOMARKER FOR NEUROLOGICAL COMPLICATIONS OF PREGNANCY  
Methods for diagnosing and treating conditions associated with life-threatening neurological complications are provided. The methods involve in some aspects the identification of oxLDL and LOX-1...
US20140378427 CABAZITAXEL-PLATINUM NANOPARTICLES AND METHODS OF USING SAME  
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum compound having a heterocycle ligand....
US20100316628 AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS  
The present invention relates to a novel method of preventing and/or treating respiratory disorders and respiratory-related complications in a subject by inhibiting the release of nitric oxide...
US20140343028 METHODS OF TREATING ORAL MUCOSITIS  
Methods and kits for treating oral mucositis are disclosed. The treatment comprises administering to a patient in need thereof a Reactive Oxygen Species scavenger in a pharmaceutically acceptable...
US20130225545 PORPHYRIN TREATMENT OF NEURODEGENERATIVE DISEASES  
Compositions and methods of treating a neurodegenerative disorder are disclosed herein.
US20150023914 USE OF TELLURIUM COMPOUNDS FOR THE TREATMENT ACTINIC KERATOSIS  
Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a...
US20110046100 Texaphyrin solutions and pharmaceutical formulations  
A packaging system is described for a drug that provides protection from contamination, crystallization and/or degradation of the drug during storage of the system prior to its use. The packaging...
US20150216875 MODULATING THE PRODUCTION OF NEURONS AND/OR OLIGODENDROCYTES FROM WHITE MATTER PROGENITOR CELLS  
The present invention relates to a method of modulating production of neurons and/or oligodendrocytes from neural progenitor cells of human white matter and to a method of treating a subject for a...
US20140073619 METHOD FOR TREATING CHRONIC PAIN  
The present invention provides analgesic compounds comprising at least one modified metalloporphyrin compound. Also provided are methods of treating pain by orally administering an analgesic...
US20150231150 SUBSTITUTED PORPHYRINS  
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
US20140011794 SUBSTITUTED PORPHYRINS  
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
US20120214780 SUBSTITUTED PORPHYRINS  
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
US20110065679 Substituted Porphyrins  
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
US20130084275 Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling  
The present invention relates generally to methods and compositions for reducing Interleukin-4 or Interleukin-13 signaling, in particular to treat asthma and atopic dermatitis. The inventors have...
US20110165065 MEANS FOR THE DETECTION AND TREATMENT OF PROSTATE CELLS  
The present invention relates to a composition for the detection and the treatment of prostate cells and to methods for the diagnostic and therapeutic treatment of a human being using the...
US20050244466 Photodynamic therapy in conjunction with intraocular implants  
A method for treating an ocular condition is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory component and a bioerodible...
US20140335025 TARGETING CORROLES FOR TUMOR TOXICITY AND MRI  
Disclosed herein are compositions comprising a targeted corrole nanoparticle; and an acceptable excipient. Also disclosed are compositions comprising a targeted corrole nanoparticle; and an...
US20140364406 Method Of Treating Or Preventing Pathologic Effects Of Acute Increases In Hyperglycemia And/Or Acute Increases Of Free Fatty Acid Flux  
One aspect of the present invention relates to a method of treating or preventing pathologic sequelae of acute hyperglycemia and/or increased fatty acid flux in a subject. This method involves...
US20120329767 Methods and Compositions for Treating Cancer  
The present invention relates to uses or methods for treating proliferative diseases, in particular cancer, implementing ruthenium compounds, as well as to composition containing same.
US20120264725 SUBSTITUTED PORPHYRINS  
Substituted metalloporphyrin compounds are described, along with pharmaceutical compositions containing the same, and methods of use thereof in protecting cells from oxidant-induced toxicity and...
US20150216923 Biochemical Scaffolds for Modulating Cell Function  
A biochemical scaffold for regulating mammalian cell function, including a bioenergetic platform and a vibrational platform, the bioenergetic platform comprising a Krebs cycle modulator,...
US20130237511 Copper Ion Delivery Platform for Pharmaceutical Agents  
Methods for utilizing copper ions to bind to and help transport medicinal agents that contain a nitrogen atom or atoms are disclosed. The copper ion or ions serve as a delivery platform for a...
US20050244500 Intravitreal implants in conjuction with photodynamic therapy to improve vision  
A method for treating a posterior ocular condition so as to improve vision is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory...
US20080085881 Stop-and-go oxaliplatin treatment regimens  
Methods of treating an oxaliplatin-sensitive cancer are disclosed in which a therapy comprising oxaliplatin is initiated, continued until a predetermined endpoint, stopped, then reintroduced after...
US20140308309 COMPOSITION COMPRISING CHLORELLA EXTRACT FOR PREVENTING OR TREATING LIVER DISEASE  
The present invention relates to a composition comprising chlorella extract for preventing or treating liver diseases. The composition comprising the chlorella extract according to the present...
US20150224202 FORMULATIONS AND USES FOR MICROPARTICLE DELIVERY OF ZINC PROTOPORPHYRINS  
Formulations and methods of use thereof that relate to biocompatible delivery of zinc protoporphyrin (ZnPP) are provided. In some embodiments, the ZnPP is formulated for oral delivery....
US20060217291 Radiosensitizer  
There is provided a radiosensitizer containing an iron compound, more specifically, a radiosensitizer containing an iron compound selected from an inorganoiron compound, such as iron chloride,...
US20070293467 Demethyl-Cantharidin Platinum Complex Isomers and Their Use  
The present invention provides a stereo-isomer of the demethylcantharidin platinum complex of formula I and use thereof. The stereo-isomer inhibits the growth of cisplatin, carboplatin or...
US20150125550 APPLICATION OF 2,9-DI-SEC-BUTYL-1,10-PHENANTHROLINE AS A GLIOBLASTOMA TUMOR CHEMOTHERAPY  
A method of inhibiting cancer cell growth is provided. In some versions, the method includes exposing lung cancer cells or glioma cells to 2,9-di-sec-butyl-1,10-phenanthroline (SBP) or derivatives...
US20150246057 Metalloporphyrin Neurological Treatments  
Methods and compositions for treating a subject suffering from exposure to a chemical threat agent are disclosed.
US20070060557 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage  
Methods for preventing and treating damage to the optic nerve and/or retina by the use of SOD mimics, particularly pentaazacycle Mn(II) complex SOD mimics, are disclosed.
US20070196428 Nitric oxide generating medical devices  
Medical devices having a catalyst capable of catalyzing the generation of nitric oxide attached to the medical device and methods of treating a vascular condition using the devices are provided.
US20120039800 Platinum Acridine Anti-Cancer Compounds And Methods Thereof  
Acridine containing cisplatin compounds are disclosed that show greater efficacy against cancer than other cisplatin compounds.
US20130071495 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR USE IN THERAPEUTIC METHODS AND SCREENING METHOD RELATING THERETO  
The present invention relates to an inhibitor of glycogen synthase kinase 3 (GSK-3) for use in a method of treating or preventing emphysema, a method of activating an emphysema cell, an activated...
US20090099150 Methotrexate Combinations For Treating Inflammatory Diseases  
Compounds, methods and kits for treating inflammatory diseases are disclosed. The treatment comprises administering to a patient in need thereof, methotrexate and a Reactive Oxygen Species...
US20110184333 PHOTOLABILE CAGED TRANSITION METAL COMPLEXES AND METHODS OF USING THE SAME  
The present invention provides compounds of Formula I: (I) along with compositions comprising the same and methods of using the same, such as for photodynamic therapy in the treatment of cancer.
US20050026867 Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain  
Herein is disclosed a composition, comprising a superoxide dismutase mimic (SODm) associated with hyaluronic acid (HA), wherein the composition is a liquid at about 37° C. The composition is...

Matches 1 - 50 out of 296 1 2 3 4 5 6 >